Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.465 USD | -1.00% | -6.50% | +68.31% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.31% | 255M | |
+31.46% | 49.46B | |
+1.68% | 42.58B | |
+49.00% | 42.49B | |
-5.26% | 29.09B | |
+12.61% | 26.61B | |
-23.84% | 18.64B | |
+8.02% | 13.16B | |
+30.78% | 12.55B | |
+24.03% | 12.1B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Design Therapeutics : Goldman Sachs Initiates Design Therapeutics at Neutral Rating With $28 Price Target